Evidence map›Paper›PMID 22020067›Full record

ArticleNature methods2011

A scalable pipeline for highly effective genetic modification of a malaria parasite.

Claudia Pfander, Burcu Anar, Frank Schwach, Thomas D Otto, Mathieu Brochet, Katrin Volkmann, Michael A Quail, Arnab Pain, Barry Rosen, William Skarnes and 2 more

Abstract read
In one paragraph

Article in Nature methods, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
6.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 107 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. AScience advances · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Fast and efficient generation of a full-length balancer chromosome by a single Cre/loxP recombination event.Mammalian genome : official journal of the International Mammalian Genome Society · 2022
    Article
  13. GeneTargeter: AutomatedThe CRISPR journal · 2022
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. CaScience advances · 2021
    Article
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 2 countries.

Claudia PfanderThe Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK.
Burcu Anar
Frank Schwach
Thomas D Otto
Mathieu Brochet
Katrin Volkmann
Michael A Quail
Arnab Pain
Barry Rosen
William Skarnes
Julian C Rayner
Oliver Billker
Wellcome Sanger Institute · GB

Funding

Medical Research Council G0501670Medical Research Council G0501670(76331)Wellcome Trust 089085Wellcome Trust WT089085/Z/09/Z
6 · The paper itself

Abstract

In malaria parasites, the systematic experimental validation of drug and vaccine targets by reverse genetics is constrained by the inefficiency of homologous recombination and by the difficulty of manipulating adenine and thymine (A+T)-rich DNA of most Plasmodium species in Escherichia coli. We overcame these roadblocks by creating a high-integrity library of Plasmodium berghei genomic DNA (>77% A+T content) in a bacteriophage N15-based vector that can be modified efficiently using the lambda Red method of recombineering. We built a pipeline for generating P. berghei genetic modification vectors at genome scale in serial liquid cultures on 96-well plates. Vectors have long homology arms, which increase recombination frequency up to tenfold over conventional designs. The feasibility of efficient genetic modification at scale will stimulate collaborative, genome-wide knockout and tagging programs for P. berghei.

Indexed as

Genetic EngineeringDNA, ProtozoanDNA, RecombinantEscherichia coliGene LibraryGenetic VectorsGenome, ProtozoanHomologous RecombinationMalariaPlasmodium bergheiDNA, ProtozoanDNA, Recombinant

Identifiers

PMID22020067
PMCPMC3431185
OpenAlexW2059401761

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.